April 14, 2020
As COVID-19 continues to spread, so does its profound impact on all aspects of life and business, including M&A and private equity dealmaking. Whether you are a buyer, seller or adviser, it is critical to stay up to speed on what is proving to be a constantly evolving area. This special installment of Dealology will help you navigate some of the challenges faced with transactions in the time of the pandemic, including:
Antitrust timing
Rep & warranty insurance – availability, pricing, timing, exclusions, due diligence
M&A and PE deal terms – purchase price, working capital target/peg, leverage, due diligence, material adverse effect
The people factor